An email discussing the development and potential of a new 'liquid biopsy' blood test for cancer detection and monitoring. The test, developed by Boston scientists and Johnson & Johnson, can detect a single cancer cell among a billion healthy ones. It aims to improve cancer treatment by predicting effective therapies and monitoring treatment success. The test uses a microchip with antibodies to capture cancer cells from blood samples. It is being studied by major cancer centers and is part of a $15 million grant from the Stand Up to Cancer telethon.
documents/EFTA00901699.pdf
{}